BioCentury | Nov 17, 2014
Company News

Targovax management update

...CEO, effective Jan. 12, 2015, currently a corporate advisor at Acino Holding AG , which Nordic Capital...
BioCentury | Apr 15, 2013
Company News

Innovative Technologies Group, SCA-Molnylcke Clinical Products deal

...SCA sold its Molnylcke clinical products division for $200 million to Nordic Capital and Tamro Oy, a...
BioCentury | May 7, 2012
Company News

Fougera, Novartis deal

...€9.6 billion ($13.8 billion). Fougera's sellers are a group of private equity firms led by Nordic Capital...
BioCentury | May 3, 2012
Company News

Sandoz to acquire former Nycomed dermatology unit

...9.6 billion ($13.8 billion). Fougera's sellers are a group of private equity firms led by Nordic Capital...
BioCentury | Aug 1, 2011
Company News

Nycomed unveils team for dermatology business

...year. Nycomed also said Nycomed US will continue to be owned by private equity firms Nordic Capital...
BioCentury | May 23, 2011
Strategy

Takeda's global boost

...had €4 billion in debt and €504 million in cash. Kristoffer Melinder, managing partner at Nordic Capital...
...from its ownership in Nycomed, other than to say it was "very healthy." He said Nordic Capital...
BioCentury | Apr 18, 2011
Company News

Binding Site deal

...Private equity fund Nordic Capital Fund VII acquired The Binding Site from founder Jo Bradwell. Bradwell will...
BioCentury | Sep 15, 2008
Finance

Ebb & Flow

...the pharma closed a $4.1 billion cash sale of its ConvaTec wound care business to Nordic Capital...
BioCentury | Aug 4, 2008
Company News

Bristol-Myers, Avista Capital Partners, Nordic Capital A/S deal

...Avista Capital and Nordic Capital completed their previously announced acquisition of Bristol-Myers’ ConvaTec wound care, ostomy care...
...12). Bristol-Myers Squibb Co. (NYSE:BMY), New York, N.Y. Avista Capital Partners , New York, N.Y. Nordic Capital...
BioCentury | Aug 4, 2008
Strategy

BMS: It's about the cash

...the closing of the $4.1 billion sale of the pharma’s ConvaTec wound care business to Nordic Capital...
Items per page:
1 - 10 of 25
BioCentury | Nov 17, 2014
Company News

Targovax management update

...CEO, effective Jan. 12, 2015, currently a corporate advisor at Acino Holding AG , which Nordic Capital...
BioCentury | Apr 15, 2013
Company News

Innovative Technologies Group, SCA-Molnylcke Clinical Products deal

...SCA sold its Molnylcke clinical products division for $200 million to Nordic Capital and Tamro Oy, a...
BioCentury | May 7, 2012
Company News

Fougera, Novartis deal

...€9.6 billion ($13.8 billion). Fougera's sellers are a group of private equity firms led by Nordic Capital...
BioCentury | May 3, 2012
Company News

Sandoz to acquire former Nycomed dermatology unit

...9.6 billion ($13.8 billion). Fougera's sellers are a group of private equity firms led by Nordic Capital...
BioCentury | Aug 1, 2011
Company News

Nycomed unveils team for dermatology business

...year. Nycomed also said Nycomed US will continue to be owned by private equity firms Nordic Capital...
BioCentury | May 23, 2011
Strategy

Takeda's global boost

...had €4 billion in debt and €504 million in cash. Kristoffer Melinder, managing partner at Nordic Capital...
...from its ownership in Nycomed, other than to say it was "very healthy." He said Nordic Capital...
BioCentury | Apr 18, 2011
Company News

Binding Site deal

...Private equity fund Nordic Capital Fund VII acquired The Binding Site from founder Jo Bradwell. Bradwell will...
BioCentury | Sep 15, 2008
Finance

Ebb & Flow

...the pharma closed a $4.1 billion cash sale of its ConvaTec wound care business to Nordic Capital...
BioCentury | Aug 4, 2008
Company News

Bristol-Myers, Avista Capital Partners, Nordic Capital A/S deal

...Avista Capital and Nordic Capital completed their previously announced acquisition of Bristol-Myers’ ConvaTec wound care, ostomy care...
...12). Bristol-Myers Squibb Co. (NYSE:BMY), New York, N.Y. Avista Capital Partners , New York, N.Y. Nordic Capital...
BioCentury | Aug 4, 2008
Strategy

BMS: It's about the cash

...the closing of the $4.1 billion sale of the pharma’s ConvaTec wound care business to Nordic Capital...
Items per page:
1 - 10 of 25